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Off-pump Coronary Artery Bypass Grafting (OPCAB) is the latest innovation in cardiac
surgery. However OPCAB is not adopted universally. Even there have been suggestions of
abandoning OPCAB in a special report. In India, OPCAB has been successfully adopted
across the board. There are various evidences which favor OPCAB and are discussed in this
review. The purpose of this review is to put forward the perspective of the OPCAB surgeons
of our country and critically look at the suggestion of abandoning OPCAB.
Copyright ª 2014, Cardiological Society of India. All rights reserved.1. Introduction
Off-pump coronary artery bypass grafting (OPCAB) continues
to flourish in India. There are concerns about the long-term
results of this procedure and this has led to poor acceptance
of this technique in North America. In North America it
peaked to 25% and there has been a steady decline after that.
There have been suggestions that OPCAB should be aban-
doned as it made surgeons lose their focus as regards to sur-
gical revascularization.1
We, surgeons of India, continue to evolve the technique of
OPCAB. Many of us had adopted this technique after starting
practice with on pump coronary artery bypass grafting
(ONCAB). Newer generations of surgeons have successfully
adopted this technique right from the beginning of their
career. In a country with limited resources and very poor
health insurance cover, it is commendable and praiseworthy
that surgeons have successfully innovated the technique of, mumbaisheartsurgery@
2014, Cardiological SocietOPCAB which reduces the cost of CABG. This suits the need of
the underprivileged population of the country suffering from
an epidemic of coronary artery disease. However our col-
leagues from privileged parts of the world have been reluctant
to adopt this technique.
The purpose of this review is to put forward the perspective
of the OPCAB surgeons of our country and critically look at the
suggestion of abandoning OPCAB.2. OPCAB and conversion to ONCAB
Rate of OPCAB conversion to ONCAB is inversely proportional
to the surgeons experience and OPCAB volume in a center.
One can argue thatmany of these conversions are attributable
to the panic reaction of inexperienced surgeons. We reported
that near zero OPCAB conversion to ONCAB in unselected
consecutive patients can be achieved by following a stan-
dardized protocol for hemodynamic stability and by judiciousgmail.com.
y of India. All rights reserved.
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Similar protocol is reported from other parts of India.3 Sur-
geons in our country including the author are routinely per-
forming OPCAB with MI <24 h, critical left main disease, poor
left ventricular ejection fraction, dilated heart, ischemic
mitral regurgitation and reoperative CABG. It is universal
practice in India to use IABP for hemodynamic compromise
refractory to inotropic therapy. Conversion is reserved for
intractable ventricular arrhythmia refractory to IABP, medical
therapy, multiple shocks and corrections of precipitating
factors, if any. Moreover there are no studies of timely use of
inotropic therapy and IABP on rate of conversion of OPCAB to
ONCAB.
Majority of the surgeons practicing OPCABs have not
converted to ONCAB for years.4 Similar results have been
reported by our younger colleagues who have learned
OPCAB from us. This shows that very low rate of OPCAB
conversion can be easily achieved by change of mindset.
OPCAB conversion is history and cannot be used as a point
against OPCAB.3. OPCAB and graft patency
Randomized controlled studies BHACAS5 and SMART6 have
conclusively proven that OPCAB and ONCAB have similar
graft patency. Multicenter CORONARY7 showed similar result
at 1 year in spite of high OPCAB to ONCAB conversion rate
(7.9%). This results are not duplicated in ROOBY trial8 which
has 12.4% OPCAB conversion rate. Such high conversion rate
proves the inexperience of the OPCAB surgeon and this ex-
plains the lower graft patency.
Graft patency is dependent on many factors. Surgeon
dependent factors will be how gently the conduit is handled
and harvested, anastomosis technique and various other
technical factors. All these will not vary for a particular sur-
geon because his basic techniquewill remain the same in both
OPCAB and ONCAB. SMART6 has conclusively proven that
when performed by the same surgeon there were no differ-
ences in the long term graft patency. If OPCAB was inferior, it
would have been reflected in the SMART trial. But in a very
biased review,1 it was concluded that OPCAB by an expert did
not demonstrate superiority of OPCAB. It will be pertinent to
argue, if one surgeon in the United States has been able to
achieve OPCAB results comparable to ONCAB then why is the
rest of the community not following? Is it inability to retrain or
relearn? Majority of the OPCAB surgeons in India did observe
very few OPCAB in their training period. But they have been
able to retrain themselves in this technique. It may be argued
it is the technique and experience of the surgeon that de-
termines graft patency rather than OPCAB or ONCAB. So
inferior graft patency rate cannot be a valid argument against
OPCAB.4. OPCAB and complete revascularization
There are concerns about complete revascularization during
OPCAB. It is noted in SMART6 trial that complete revascu-
larization is possible during OPCAB. Earlierrevascularization of posterolateral and inferior vessels used
to be considered difficult. But with refinement of the tech-
nique these vessels are routinely grafted during OPCAB.
Actually, grafting these vessels are easier during OPCAB as
no assistance is required to retract the heart like in ONCAB.
Wehave reportedaverageof 4.18graftsperpatientand71.1%
patients received 4 ormore grafts.2 The author had successfully
performedupto 9 grafts in a patientwith diffuse coronary artery
disease.We feel that in absence of the stress of increasing aortic
cross clamp time or cardiopulmonary bypass time, complete
revascularization is performed more often than not. This is
particularly true in patients with small vessels and diffuse cor-
onary artery disease. We sometimes even have to cut across
severely diseased segment and perform a long anastomosis
using on-lay patch technique. The methodology of this is well
documented in literature3 but still has been ignored by our col-
leagues from United States. It is common sense that a long
anastomosis will increase the cardiopulmonary bypass and
clamp time and deter surgeons from performing complete
revascularization. With off-pump my personal threshold for
sequentially grafting the LAD has become lowefor distal LAD
diseaseweareusing sequential LIMA tograftmidanddistal LAD
while the ONCAB surgeons are inclined to leave the distal LAD
disease to medical management.
Same argumentwill hold for deep intra-myocardial coronary
arteryandsmall sizedcoronaryvessel. Ifadeep intra-myocardial
vessel isnot visibleeasily, duringONCABonewill be inclinednot
to graft that vessel. But during OPCAB we can search the vessel
and if required relook at the angiography in the middle of the
surgery. This luxury is not available during ONCAB. Innovative
techniques9 reported from our country to tackle intra-myocar-
dial arteries are often ignored by our western colleagues. The
author feels that marsupialization can be performed during
OPCAB as there is no stress of increasing pump time.
However the rare cases of intracavitory coronary artery
cannot be grafted during OPCAB. So presence of intracavitary
coronary artery is a contraindication to OPCAB.
Diffuse CAD is prevalent in our part of the world
particularly in young patients.3 The spectrum of diffuse
CAD which we have to treat frequently in our part of the
world will often be labeled inoperable elsewhere. Various
innovative techniques have been developed like on-lay
patch plasty of distal disease which is routinely practiced
by many OPCAB surgeons. Performing comparable revas-
cularization during ONCAB will result in longer bypass and
ischemic time. Coronary endarterectomy can be easily
performed if required, during OPCAB. Fig. 1 shows a spec-
imen removed from LAD of a very young patient with
excellent early result (Fig. 2 and Fig. 3). It is not infrequent
to find a patient who requires multiple endarterectomies to
be performed (Fig. 4) and it has been found out it is easier to
perform coronary endarterectomy during OPCAB.
Lateral wall revascularization difficulty during OPCAB is
history. We are routinely revascularizing lateral wall ves-
sels without any hemodynamic instability. Even ramus
intermedius near AV groove can be easily grafted. Patients
with dilated heart and poor ventricle benefit most from
OPCAB and these are routinely performed in our country.
Re-operative CABG is not a contraindication to OPCAB even
in presence of low EF. This is adopted universally by the
Fig. 3 e CT coronary angio followup showing patent LIMA
to LAD.
Fig. 1 e Atheroma removed from LAD during OPCAB.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 2 0 3e2 0 7 205surgeons in our part of the world. Present Prime Minister of
India underwent redo CABG using off-pump technique (first
CABG was done outside India several years back.) This proves
a point in favor of the advanced level of refinement of the
OPCAB technique in our country.5. OPCAB and stroke
It is now well established that avoiding cardiopulmonary
bypass is not enough to avoid stroke after CABG. All recent
trials had conclusively proven that stroke is amajor drawback
of CABGwhen compared with PCI. Stroke is probably themost
devastating complication after CABG and in an otherwise
healthy patient can be worse than dying. OPCAB with aortic-
no-touch can drastically reduce the incidence of stoke.106. OPCAB and arterial graft
There is conclusive evidence that bilateral IMA is superior to
single IMA.10,11 OPCAB with LIMA-RIMA y graft is widely
practiced in India. This technique has been pioneered by DrFig. 2 e CT coronary angio followup showing patent LIMA
to LAD.Sudhanshu Bhattacharia from Mumbai and has been suc-
cessfully used by him. His results in OPCAB with bilateral IMA
have become a bench mark in India for all OPCAB surgeons to
emulate.
We have reported a simple technique of OPCAB with
aortic-no-touch12,13 which is technically less demanding and
easily reproducible. IMA has best patency rate and OPCAB
with aortic-no-touch which also has least incidence of stroke
could be considered theoretically the best surgical
revascularization.7. Medical therapy after OPCAB
OPCAB like any other major surgery produces hypercoagula-
ble state which may affect graft patency. In ONCAB, cardio-
pulmonary bypass induced coagulopathy provides some
protection against graft thrombosis. The trials showing infe-
rior graft patency after OPCAB may have resulted from anyFig. 4 e Three coronary endarterectomy performed in a 39-
year-old on beating heart.
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than deficient surgical technique
a) delayed or absent potent antiplatelet therapy after OPCAB
b) hypercoaguable state induced by OPCAB (like any major
surgery)
c) absence of protective effect of coagulopathy induced by
cardiopulmonary bypass.
Recent meta-analysis suggests dual antiplatelet therapy
improves graft patency14 after CABG. This meta-analysis
analysed 5 randomized controlled trials and 6 observational
studies involving 25728 patients. The conclusion of the meta-
analysis:
Early SVG occlusion rate was reduced with dual anti-
platelet (p ¼ 0.02).
In-hospital 30 day mortality was lower with aspirin and
clopidogrel (p < 0.0001).
In a pooled analysis of studies involving off-pump CABG
compared to aspirin alone, dual antiplatelet therapy reduced
the risk of perioperative myocardial infarction and saphenous
graft occlusion by 68% (47%e71%) and 55% (2%e79%)
respectively.
Randomized controlled trial15 concluded that clopidogrel
plus aspirin is beneficial after OPCAB. It has been our practice
to use clopidogrel early after OPCAB to improve graft patency.
In patients with small vessels, diffuse distal disease or where
coronary endarterectomy has been performed, clopidogrel
may be started as early as 2 h. As a personal preference,
starting of aspirin is delayed for few days to avoid gastric
intolerance. The author has been using dual antiplatelet
therapy for almost a decade and strongly advocates this after
OPCAB.
According to current guidelines, dual antiplatelet therapy
(DAPT) that includes aspirin and clopidogrel are recom-
mended after percutaneous coronary intervention (PCI). It has
been proven to be safe. Post CABG, in the hospital set up, it is
safer as patients are well monitored and any bleeding can be
easily detected. In our country, vessels are smaller & diffusely
diseased and they are more prone to occlusion in hyperco-
agulable state. There is no apparent downside of giving the
OPCAB patients dual antiplatelet therapy.8. OPCAB and cost
There is no study in our country comparing cost of OPCAB and
ONCAB but the Canadian registry shows lower cost of
OPCAB.16 Cost is a major factor in India particularly when a
large number of people have to pay for their treatment in
absence of government funded healthcare. CABG is often
offered as a package in our country e but almost all hospitals
put a limit on the cost of medicines and consumables
permitted in the package. The cost of oxygenator, tubing pack,
cannulae and sutures that are used during ONCAB are billed to
the patient. Whereas in OPCAB the stabilizer that is used can
be reused after ETO sterilization4 and the price is divided
among a number of patients usually 10 (range is 5e25
depending on the hospital). Moreover there are additional
savings because of shorter ICU stay and ventilation alongwithlower blood and blood product usage.17,18 So the final bill of an
OPCAB patient is always on the lower side when compared to
that of an ONCAB patient. Significantly lower OPCAB costs
compared to ONCAB e have helped in competitive pricing of
CABG surgery in private healthcare sector in India.9. OPCAB vs ONCAB trials
ONCAB is a standard safe procedure with low complication
rate in normal risk patients. To observe a significant differ-
ence in complication rate, large number of operations will be
required. This has been clearly depicted in the CORONARY7
trial. Studies comparing high risk patient between OPCAB vs
ONCAB has proved better outcome with OPCAB patient.19e2110. Blood and blood product usage
All studies have conclusively proven that use of blood and
products requirements are significantly lower for OPCAB as
compared to ONCAB.17 Studies have proven that early 30 days
postoperative mortality is inversely proportional to trans-
fusion requirement. Moreover, this has an immense impact in
development of OPCAB in tier 2 city and smaller hospitals in
metro city without in-hospital blood bank facility. OPCAB can
also be easily performed in patients on potent antiplatelet
agents or thrombolytic therapy after acute MI.11. Conclusion
OPCAB is here to stay. Numbers of OPCAB have been
increasing in India. This technique has been successfully
adopted by the younger surgeons in India ewhich proves this
is a reproducible technique. Moreover, higher incidence of
OPCAB in highly competitive private healthcare sector proves
superior results with this technique. Personally the author
believes that in absence of the stress of increasing cardio-
pulmonary bypass time or aortic cross clamp time, it is
possible to perform as many grafts required even for small
vessels and also more precise anastomosis can be done.
Similar operation during ONCAB will prolong cardiopulmo-
nary bypass and aortic cross clamp time with its detrimental
effects.2 Published articles have proven that complete revas-
cularization is possible using OPCAB technique.22
In patients with dilated heart it is possible to perform
OPCAB without any difficulty. Moreover in patients with poor
left ventricular ejection fraction, it is often easier to perform
OPCAB because of less movement of the heart facilitates
precise anastomosis. During OPCAB we often use both IMA
and aortic-no-touch technique. OPCAB with aortic-no-touch
has a low stroke rate after CABG which is comparable to PCI.
We also believe that OPCAB with aortic-no-touch using both
IMA is far more cost effective than multi-vessel PCI in a
country like India where patient has to pay for their
treatment.
Hypercoagulable state after OPCAB may contribute to poor
graft patency rate in some of the studies. This aspect has
never been looked into so far and needs further study.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 2 0 3e2 0 7 207OPCABwhen performed by competent surgeon has proven
long term graft patency which is similar to ONCAB.6 Poorly
performed OPCAB with high conversion rate by surgeon
inexperienced with the technique cannot be the excuse to
abandon OPCAB.8 Any surgeon with suboptimal result with
OPCAB should get retrained in OPCAB. Benefit of OPCAB is
proven in high risk patients because of lower incidence of
complications. OPCABwith aortic-no-touch (least incidence of
stroke) is the best surgical revascularization technique with
least complications as on today.Conflicts of interest
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